Navegando por Palavras-chave "intracranial hemorrhage"
Agora exibindo 1 - 3 de 3
Resultados por página
Opções de Ordenação
- ItemSomente MetadadadosGinkgo biloba and Cerebral Bleeding A Case Report and Critical Review(Lippincott Williams & Wilkins, 2011-03-01) Pedroso, Jose Luiz [UNIFESP]; Henriques Aquino, Camila Catherine [UNIFESP]; Escorcio Bezerra, Marcio Luiz [UNIFESP]; Baiense, Robson Fantinato [UNIFESP]; Suarez, Marcelo Mendes [UNIFESP]; Dutra, Livia Almeida [UNIFESP]; Braga-Neto, Pedro [UNIFESP]; Barsottini, Orlando Graziani Povoas [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)Ginkgo biloba is a herbal medication that is often used worldwide. Although side effects are uncommon, G. biloba has been associated with serious bleeding complications, especially intracranial hemorrhage. We report the case of a young woman who made chronic use of G. biloba and suffered from cerebral bleeding without any structural abnormalities. Several studies have pointed to the association between G. biloba and intracranial hemorrhage.
- ItemSomente MetadadadosHemorragia intracraniana fetal: achados ultrassonográficos em fetos com diagnóstico confirmado por ressonância magnética(Universidade Federal de São Paulo (UNIFESP), 2016-12-21) Iani, Leonardo Jorge [UNIFESP]; Abdala, Nitamar [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)Objective: To recognize and describe the ultrasonographic findings of fetuses diagnosed with intracranial hemorrhage, confirmed by magnetic resonance imaging. Patients and methods: 411 MRI exams of fetuses with CNS changes detected on routine ultrasonography, and confirmed by a specialist in fetal medicine in our service, performed from 2004 to 2015, were retrospectively reviewed. Fetuses with intracranial hemorrhage confirmed by MRI were divided into 3 groups, according to their location: encephalic (group 1), extra-encephalic (group 2) and encephalic and extra-encephalic (group 3). Group 1 was subdivided into 4 types: subependymal (1A); Subependymal with extension to white matter or parenchyma thinning (1B); Subependymal to the cortex ie the entire parenchyma thickness (1C) and diffuse encephalic hemorrhage supra and infratentorial (1D). After this division such fetuses had their ultrasound reports reviewed. Results: MRI findings: 5.8% (24/411) presented intracranial hemorrhage; 75% (18/24) encephalic (group 1); 12.5% ??(3/24) extraencephalic (group 2); 12.5% ??(3/24) encephalic and extra-encephalic (group 3). Among the fetuses with brain hemorrhage (group 1), subependymal involvement (1A) was observed in 22% (4/18); Subependymal and adjacent white matter (1B) in 28% (5/18); Of all parenchymal thickness (1C) in 44% (8/18) and diffuse of the cerebral parenchyma and cerebellum (1D) in 5% (1/18). In group 2 all the fetuses presented arteriovenous malformation (AVM): 33.3% (1/3) AVM pial; 33.3% (1/3) dural MAV and 33.3% (1/3) Galene vein malformation (MFVG). In group 3, it was observed an AVM of the MFVG type, with major cerebral ischemia in 33.3% (1/3) and subdural and subarachnoid haemorrhage, associated with involvement of the cerebral parenchyma in 66.7% (2/3). Ultrasound findings: ventriculomegaly was the most prevalent finding (87.5%, 21/24), isolated in only 1 case and with a statistically significant association with peri or intraventricular changes (p = 0.028), with masses (p = 0.009) And with deviations of the midline structures (p = 0.013). Conclusion: ventriculomegaly is the main ultrasonographic alteration related to intracranial hemorrhages, especially when associated with other findings, detectable in routine ultrasonography, allowing diagnostic follow-up with dedicated laboratory and imaging exams
- ItemSomente MetadadadosSuccessful Intra-arterial Thrombolysis in a Patient with an Intracranial Meningioma(Elsevier B.V., 2013-11-01) Baiense, Robson Fantinato [UNIFESP]; Abrahao, Agessandro [UNIFESP]; Ricarte, Irapua F. [UNIFESP]; Fukuda, Thiago G. [UNIFESP]; Oliveira, Ricardo A. [UNIFESP]; Silva, Gisele S. [UNIFESP]; Costa, Maristela; Teixeira, Manoel J.; Hosp Coracao; Universidade Federal de São Paulo (UNIFESP)Alteplase (recombinant tissue plasminogen activator [rt-PA]) label approval by the Food and Drug Administration remarks the contraindication of its use with known intracranial neoplasm because of potential bleeding complications. Despite this concern, the real risk of intracerebral bleeding in patients with intracranial neoplasms treated with rt-PA is unknown, and there are few reports of thrombolysis in patients with brain tumors. We report a case of a 78-year-old man who was seen in our emergency department within 2 hours from sudden onset of aphasia, right-sided hemiplegia, hypoesthesia, and homonymous hemianopsia. the National Institutes of Health Stroke Scale (NIHSS) score at admission was 20. Intra-arterial thrombolysis was performed with administration of .3 mg/kg of alteplase combined with mechanical thrombectomy. At discharge, his NIHSS score was 1, and after 90 days, his modified Rankin score was 1. To our knowledge, this is the first report of intra-arterial thrombolysis in a patient with acute ischemic stroke with an intracranial tumor.